IBDEI2UJ ; ; 04-FEB-2020
 ;;3.0;IB ENCOUNTER FORM IMP/EXP;;FEB 04, 2020
 Q:'DIFQR(358.3)  F I=1:2 S X=$T(Q+I) Q:X=""  S Y=$E($T(Q+I+1),4,999),X=$E(X,4,999) S:$A(Y)=126 I=I+1,Y=$E(Y,2,999)_$E($T(Q+I+1),5,999) S:$A(Y)=61 Y=$E(Y,2,999) X NO E  S @X=Y
Q Q
 ;;^UTILITY(U,$J,358.3,45401,2)
 ;;=^5015690
 ;;^UTILITY(U,$J,358.3,45402,0)
 ;;=N43.3^^172^2268^5
 ;;^UTILITY(U,$J,358.3,45402,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,45402,1,3,0)
 ;;=3^Hydrocele, unspecified
 ;;^UTILITY(U,$J,358.3,45402,1,4,0)
 ;;=4^N43.3
 ;;^UTILITY(U,$J,358.3,45402,2)
 ;;=^5015700
 ;;^UTILITY(U,$J,358.3,45403,0)
 ;;=N52.9^^172^2268^10
 ;;^UTILITY(U,$J,358.3,45403,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,45403,1,3,0)
 ;;=3^Male erectile dysfunction, unspecified
 ;;^UTILITY(U,$J,358.3,45403,1,4,0)
 ;;=4^N52.9
 ;;^UTILITY(U,$J,358.3,45403,2)
 ;;=^5015763
 ;;^UTILITY(U,$J,358.3,45404,0)
 ;;=L03.031^^172^2269^3
 ;;^UTILITY(U,$J,358.3,45404,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,45404,1,3,0)
 ;;=3^Cellulitis of right toe
 ;;^UTILITY(U,$J,358.3,45404,1,4,0)
 ;;=4^L03.031
 ;;^UTILITY(U,$J,358.3,45404,2)
 ;;=^5009025
 ;;^UTILITY(U,$J,358.3,45405,0)
 ;;=L03.032^^172^2269^2
 ;;^UTILITY(U,$J,358.3,45405,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,45405,1,3,0)
 ;;=3^Cellulitis of left toe
 ;;^UTILITY(U,$J,358.3,45405,1,4,0)
 ;;=4^L03.032
 ;;^UTILITY(U,$J,358.3,45405,2)
 ;;=^5009026
 ;;^UTILITY(U,$J,358.3,45406,0)
 ;;=L03.90^^172^2269^4
 ;;^UTILITY(U,$J,358.3,45406,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,45406,1,3,0)
 ;;=3^Cellulitis, unspecified
 ;;^UTILITY(U,$J,358.3,45406,1,4,0)
 ;;=4^L03.90
 ;;^UTILITY(U,$J,358.3,45406,2)
 ;;=^5009067
 ;;^UTILITY(U,$J,358.3,45407,0)
 ;;=L08.9^^172^2269^32
 ;;^UTILITY(U,$J,358.3,45407,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,45407,1,3,0)
 ;;=3^Skin infection, unspec
 ;;^UTILITY(U,$J,358.3,45407,1,4,0)
 ;;=4^L08.9
 ;;^UTILITY(U,$J,358.3,45407,2)
 ;;=^5009082
 ;;^UTILITY(U,$J,358.3,45408,0)
 ;;=L29.9^^172^2269^23
 ;;^UTILITY(U,$J,358.3,45408,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,45408,1,3,0)
 ;;=3^Pruritus, unspecified
 ;;^UTILITY(U,$J,358.3,45408,1,4,0)
 ;;=4^L29.9
 ;;^UTILITY(U,$J,358.3,45408,2)
 ;;=^5009153
 ;;^UTILITY(U,$J,358.3,45409,0)
 ;;=L30.9^^172^2269^16
 ;;^UTILITY(U,$J,358.3,45409,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,45409,1,3,0)
 ;;=3^Dermatitis,Unspec
 ;;^UTILITY(U,$J,358.3,45409,1,4,0)
 ;;=4^L30.9
 ;;^UTILITY(U,$J,358.3,45409,2)
 ;;=^5009159
 ;;^UTILITY(U,$J,358.3,45410,0)
 ;;=L40.0^^172^2269^27
 ;;^UTILITY(U,$J,358.3,45410,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,45410,1,3,0)
 ;;=3^Psoriasis,Vulgaris
 ;;^UTILITY(U,$J,358.3,45410,1,4,0)
 ;;=4^L40.0
 ;;^UTILITY(U,$J,358.3,45410,2)
 ;;=^5009160
 ;;^UTILITY(U,$J,358.3,45411,0)
 ;;=L40.1^^172^2269^28
 ;;^UTILITY(U,$J,358.3,45411,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,45411,1,3,0)
 ;;=3^Pustular psoriasis, generalized
 ;;^UTILITY(U,$J,358.3,45411,1,4,0)
 ;;=4^L40.1
 ;;^UTILITY(U,$J,358.3,45411,2)
 ;;=^5009161
 ;;^UTILITY(U,$J,358.3,45412,0)
 ;;=L40.2^^172^2269^1
 ;;^UTILITY(U,$J,358.3,45412,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,45412,1,3,0)
 ;;=3^Acrodermatitis continua
 ;;^UTILITY(U,$J,358.3,45412,1,4,0)
 ;;=4^L40.2
 ;;^UTILITY(U,$J,358.3,45412,2)
 ;;=^5009162
 ;;^UTILITY(U,$J,358.3,45413,0)
 ;;=L40.3^^172^2269^29
 ;;^UTILITY(U,$J,358.3,45413,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,45413,1,3,0)
 ;;=3^Pustulosis palmaris et plantaris
 ;;^UTILITY(U,$J,358.3,45413,1,4,0)
 ;;=4^L40.3
 ;;^UTILITY(U,$J,358.3,45413,2)
 ;;=^5009163
 ;;^UTILITY(U,$J,358.3,45414,0)
 ;;=L40.4^^172^2269^25
 ;;^UTILITY(U,$J,358.3,45414,1,0)
 ;;=^358.31IA^4^2
